Abbott Competitors
| ABT Stock | USD 107.53 0.67 0.63% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Abbott Laboratories competition on your existing holdings.
Abbott |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abbott Laboratories Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Abbott Laboratories and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Abbott and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Abbott Laboratories does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Abbott Stock performing well and Abbott Laboratories Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Abbott Laboratories' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ESTA | 2.84 | 0.49 | 0.11 | (5.03) | 3.26 | 7.02 | 28.65 | |||
| XAIR | 4.58 | 0.00 | 0.00 | 0.08 | 0.00 | 8.86 | 32.65 | |||
| BIO | 1.46 | (0.20) | 0.00 | (3.08) | 0.00 | 3.74 | 10.47 | |||
| BSX | 0.85 | 0.26 | 0.23 | 1.03 | 0.55 | 2.07 | 5.27 | |||
| BVS | 2.75 | (0.13) | 0.00 | 1.29 | 0.00 | 6.42 | 15.08 | |||
| MDT | 0.84 | (0.13) | 0.00 | (0.99) | 0.00 | 1.37 | 6.33 | |||
| MYO | 4.31 | (0.20) | 0.00 | 0.02 | 4.41 | 13.12 | 40.42 | |||
| NXL | 10.60 | 3.10 | 0.31 | 23.49 | 8.28 | 35.71 | 104.74 |
Cross Equities Net Income Analysis
Compare Abbott Laboratories and related stocks such as Establishment Labs, Beyond Air, and Bio Rad Laboratories Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ESTA | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (22.2 M) | (34.9 M) | (21.1 M) | (38.1 M) | (38.1 M) | (41.1 M) | (75.2 M) | (78.5 M) | (74.6 M) |
| XAIR | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (4.8 M) | (3.7 M) | (29.7 K) | (18 M) | (6.6 M) | (19.9 M) | (22.9 M) | (43.2 M) | (55.8 M) | (50.2 M) | (47.7 M) |
| BIO | 4.3 M | 178.2 M | 169.2 M | 77.8 M | 88.8 M | 113.1 M | 28.1 M | 114.7 M | 361 M | 1.8 B | 3.8 B | 4.3 B | (3.6 B) | (637.3 M) | (605.5 M) |
| BSX | 41.8 M | 441 M | (4.1 B) | (121 M) | 267 M | (239 M) | 347 M | 104 M | 1.7 B | 4.7 B | (140 M) | 1 B | 698 M | 1.6 B | 1.7 B |
| BVS | (22.4 M) | (22.4 M) | (22.4 M) | (22.4 M) | (12.9 M) | (34.1 M) | (12.2 M) | (12.2 M) | (12.2 M) | 6.9 M | 16.4 M | 9.6 M | (213.4 M) | (156.2 M) | (148.4 M) |
| MDT | 53.4 M | 3.6 B | 3.5 B | 3.1 B | 2.7 B | 3.5 B | 4 B | 3.1 B | 4.6 B | 4.8 B | 3.6 B | 5 B | 3.8 B | 4.3 B | 4.5 B |
| MYO | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (3.7 M) | (3.6 M) | (12.1 M) | (10.3 M) | (10.6 M) | (12 M) | (10.4 M) | (10.7 M) | (8.1 M) | (8.6 M) |
| NXL | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (3.5 M) | (6.2 M) | (1.9 M) | (4.6 M) | (4.9 M) |
Abbott Laboratories and related stocks such as Establishment Labs, Beyond Air, and Bio Rad Laboratories Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Abbott Laboratories financial statement analysis. It represents the amount of money remaining after all of Abbott Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Abbott Laboratories Competitive Analysis
The better you understand Abbott Laboratories competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Abbott Laboratories' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Abbott Laboratories' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Abbott Laboratories Competition Performance Charts
Five steps to successful analysis of Abbott Laboratories Competition
Abbott Laboratories' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Abbott Laboratories in relation to its competition. Abbott Laboratories' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Abbott Laboratories in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Abbott Laboratories' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Abbott Laboratories, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Abbott Laboratories position
In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Railroads Thematic Idea Now
Railroads
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Abbott Laboratories Correlation with its peers. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.